Late‐onset hypogonadism: metabolic impact

Background Obesity and dysglycemia (comprising insulin resistance, the metabolic syndrome and type 2 diabetes), that is diabesity, are associated with reduced circulating testosterone and, in some men, clinical features consistent with androgen deficiency. Objective To review the metabolic impact of late‐onset hypogonadism. Methods Comprehensive literature search with emphasis on recent publications. Results Obesity is one of the strongest...